Sonoma Biologics, a producer of high-quality, low-cost cannabis, was founded by the Caracciolos, who had a background in science, specifically in the biotech industry. This background has influenced the founders’ operations, helping them develop standard protocols for cultivation, precisely calibrated to grow high-quality crops. This approach was key in building Sonoma’s reputation as a grower of ultra-premium Pinot Noir grapes, making it a supplier of these grapes to world-class winemakers in the Russian River Valley of Sonoma County. With the legalization of cannabis in California, Sonoma then ventured into hemp cultivation and has utilized a similar science-based approach. A recent article reads, “Just as other winemakers came to them for their grapes, cannabis start-ups reached out to them for varietal knowledge in Sonoma county, as the Caracciolos had already tested and piloted tens of varietals in their first year for climate suitability… By using exclusively organic methods to grow and taking advantage of the suitable Sonoma county climate, the company produces premium quality crops at a fraction of the cost of its competitors.”
To view the full article, visit https://ibn.fm/d2thH
About Sonoma Biologics Corp.
Sonoma Biologics is an ultra-premium cannabis grower focused on the medicinal and recreational cannabis markets. The company is led by an experienced management team with a proven track record in the large-scale agriculture business for the last decade and entry into the cannabis business in the last three years. Management has established relationships with cannabis farming, processing, manufacturing, and retail partners throughout California. For more information, visit the company’s website at www.OwnSonomaBiologics.com.
NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.